Postsurgical Intraperitoneal Tissue Repair: Implication of TGF-β

  • Nasser Chegini

Abstract

The peritoneal and serosal surfaces of organs within the peritoneal cavity are composed of mesothelial cells and submesothelial tissue that contains fibroblasts, macrophages, and blood vessels. Even with the most optimal surgical procedures, minor injuries to these surfaces cause an inflammatory response that leads to minor adhesion formations that are transient and are often absorbed within a few days, possibly by fibrinolytic mechanisms. 1–6 However, when the tissue trauma is extensive and spontaneous healing does not proceed correctly, permanent intraperitoneal adhesions may form between the peritoneum and the serosal surface of adjacent organs. These extensive adhesions are considered a pathologic state in which the continuous unity of the peritoneal wall or serosal surface of organs is destroyed, leading to impairment of their physiologic functions. Extensive fibrous adhesions are the major cause of postoperative complications such as intestinal obstruction, chronic pain, or infertility. Infertility secondary to adhesions affecting the uterus, fallopian tubes, or ovaries accounts for approximately 20% of all infertility.4

Keywords

Ischemia Lactate Heparin Serine Polypeptide 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Holtz, G. Prevention and management of peritoneal adhesions. Fertil Steril. 1984; 41: 496–497.Google Scholar
  2. 2.
    Moritz FJ, diZerega GS. Postsurgical mesothelial repair. In: DeCherney A, Hezeltine F, eds. Physiology and Pathophysiology in Reproductive Surgery. New York: CK Hall; 1985.Google Scholar
  3. 3.
    Raftery AT. Effect of peritoneal trauma on peritoneal fibrinolytic activity and intraperitoneal adhesion formation. An experimental study in rat. Eur J Surg. 1981; 13: 397–401.CrossRefGoogle Scholar
  4. 4.
    Diamond MP, Hershlag A. Adhesion formation/reformation. Prog Clin Biol Res. 1990; 358: 23–33.PubMedGoogle Scholar
  5. 5.
    Holmdahl L, Al-Jabreen M, Rinsberg B. The role of fibrinolysis in the formation of postoperative adhesions. Wound Repair Reg. 1994; 2: 171–176.CrossRefGoogle Scholar
  6. 6.
    Menzies D, Elis H. The role of plasminogen activator in adhesion prevention. Surg Gynecol Obstet. 1991; 172: 362–366.PubMedGoogle Scholar
  7. 7.
    Wahl SM, Wong H, McCartney-Francis N. Role of growth factors in inflammation and repair. J Cell Biochem. 1989; 40: 193–199.PubMedCrossRefGoogle Scholar
  8. 8.
    Cromack DT, Porras-Reyer B, Mustoe TA. Current concepts in wound healing: growth factor and macrophages interaction. J Trauma. 1990; 30: 129–133.CrossRefGoogle Scholar
  9. 9.
    Westermark B. The molecular and cellular biology of platelet-derived growth factor. Acta Endocrinol (Copenh). 1990; 123: 131–142.Google Scholar
  10. 10.
    Barnard JA, Lyons RM, Moses HL. The cell biology of transforming growth factor-(3. Biochem Biophys Acta. 1990; 1032: 79–87.PubMedGoogle Scholar
  11. 11.
    Yates RA, Nanney LB, Gates RE, King LE Jr. Epidermal growth factors and related growth factors. Int J Dermatol. 1991; 30: 687–694.PubMedCrossRefGoogle Scholar
  12. 12.
    Rappolee DA, Mark D, Banda MJ, Werb Z. Wound macrophages express TGF-aaa and other growth factors in vivo: analysis by mRNA phenotyping. Science. 1988; 41: 708–712.CrossRefGoogle Scholar
  13. 13.
    Rappolee DA, Werb Z. Macrophage-derived growth factor. Curr Topics Microbiol Immunol. 1992; 181: 87–140.CrossRefGoogle Scholar
  14. 14.
    Nathan CF. Secretory products of macrophages. J Clin Invest. 1987; 79: 319–326.PubMedCrossRefGoogle Scholar
  15. 15.
    Bennett NT, Schultz GS. Growth factors and wound healing: part II. Role in normal and chronic wound healing. Am JSurg. 1993; 166: 74–81.CrossRefGoogle Scholar
  16. 16.
    Border WA, Ruoslahti E. Transforming growth factor-f3 in disease: the dark side of tissue repair. J Clin Invest. 1992; 90: 1–7.PubMedCrossRefGoogle Scholar
  17. 17.
    Ramey JW, Archer DF. Peritoneal fluid: its relevance to the development of endometriosis. Fertil Steril. 1993; 60: 1–14.PubMedGoogle Scholar
  18. 18.
    Chegini N, Williams RS. The role of macrophages in women with and without endometriosis. In: Diamond M, Osteen K, eds. Endometrium and Endometriosis. Blackwell Sciences, 1996: In Press.Google Scholar
  19. 19.
    Brown PD, Wakefield LM, Levinson AD, Sporn MB. Physicochemical activation of latent transforming growth factor-beta’s 1, 2 and 3. Growth Factors. 1990; 3: 35–43.PubMedCrossRefGoogle Scholar
  20. 20.
    Sato Y, Tsuboi R, Lyons R, Moses H, Rifkin DB. Characterization of the activation of latent TGF- 3 by co-culture of endothelial cells and pericytes or smooth muscle cells: a self-regulating system. J Cell Biol. 1990; 111: 757–763.PubMedCrossRefGoogle Scholar
  21. 21.
    Dennis PA, Refkin DB. Cellular activation of latent transforming growth factor ß requires binding to the cation-independent mannose-6-phosphate/insulin-like growth factor receptor. Proc Natl Acad Sci USA. 1991; 88: 580–584.PubMedCrossRefGoogle Scholar
  22. 22.
    Fukasawa M, Bryant SM, Nakamura, RM, diZerega GS. Modulation of fibroblast proliferation of postsurgical macrophages. J Surg Res. 1987; 43: 513–520.PubMedCrossRefGoogle Scholar
  23. 23.
    Fukasawa M, Yanagihara DL, Rodgers KE, diZerega GS. The mitogenic activity of peritoneal tissue repair cells: control by growth factors. J Surg Res. 1989; 47: 45–51.PubMedCrossRefGoogle Scholar
  24. 24.
    Orita H, Campeau JD, Nakamura RM, diZerega GS. Modulation of fibroblast proliferation and transformation by activated macrophages during postoperative peritoneal reepithelization. Am J Obstet Gynecol. 1986; 155: 905–911.PubMedGoogle Scholar
  25. 25.
    Rodger KE, diZerega GS. Function of peritoneal exudate cells after abdominal surgery. J Invest Surg. 1993; 6: 9–23.CrossRefGoogle Scholar
  26. 26.
    Hickey MJ, DiZerega GS. Recent advances in adhesion prevention. Contemp OB/GYN. 1990; 35: 14–26.Google Scholar
  27. 27.
    Chegini N, Rossi MJ, Schultz GS, Dunn WA Jr, Masterson BJ. Cellular distribution of EGF, TGF-aaa and EGF receptor in fascia and peritoneum during healing in the rat: an autoradiographic and immunohistochemical study. Wound Rep Reg. 1993; 1: 27–40.Google Scholar
  28. 28.
    Chegini N, Gold LI, Williams RS, Masterson BJ. Localization of transforming growth factor beta isoforms TGF-(31, TGF-ß2 and TGF-ß3 in surgically induced pelvic adhesion in the rat. Obstet Gynecol. 1994; 83: 449–454.PubMedGoogle Scholar
  29. 29.
    Rong H, Tang X-M, Zhao Y, Anderson JT, Peck AB, Chegini N. Molecular analysis of intraperitoneal environment and its relationship to adhesion formation. Obstet Gynecol. 1996; submitted.Google Scholar
  30. 30.
    Rong H, Tang X-M, Zhao Y, et al. Alteration in peritoneal fluid cytokines and eicosanoids in surgically induced peritoneal adhesion exposed to surgical glove powders. Ann Surg. 1996; submitted.Google Scholar
  31. 31.
    Williams RS, Rossi AM, Chegini N, Schultz G. Effect of transforming growth factor ß on postoperative adhesion formation and intact peritoneum. J Surg Res. 1991; 52: 6570.Google Scholar
  32. 32.
    Massague J. The transforming growth factor-13 family. Annu Rev Cell Biol. 1990; 6: 597–641.PubMedCrossRefGoogle Scholar
  33. 33.
    Massague J, Boyd FT, Andres JL, Cheiftez S. TGF-13 receptors and TGF-13 binding proteoglycans: recent progress in identifying their functional properties. Ann NY Acad Sci. 1990; 593: 59–72.PubMedCrossRefGoogle Scholar
  34. 34.
    ten Dijke P, Yamashita H, Ichijo H, et al. Characterization of type I receptors for transforming growth factor-(3 and activin. Science. 1994; 264: 101–104.PubMedCrossRefGoogle Scholar
  35. 35.
    Wrana JL, Attisano L, Wieser R, Ventura F, Massagia J. Mechanism of activation of the TGF-ß receptor. Nature. 1994; 370: 341–347.PubMedCrossRefGoogle Scholar
  36. 36.
    Cromack DT, Sporn MB, Roberts AB, Merino MJ, Dart LL, Norton JA. Transforming growth factor ß levels in rat wound chambers. J Surg Res. 1987; 42: 622–628.PubMedCrossRefGoogle Scholar
  37. 37.
    Terrell TG, Working PK, Chow CP, Green JD. Pathology of recombinant human transforming growth factor 01 in rats and rabbits. Int Rev Exp Pathol. 1993; 34: 43–67.PubMedGoogle Scholar
  38. 38.
    Ketteler M, Noble NA, Border WA. Increased expression of transforming growth factor-beta in renal disease. Curr Opin Nephrol Hypertens. 1994; 3: 446–452.PubMedCrossRefGoogle Scholar
  39. 39.
    Border WA. Transforming growth factor beta and the pathogenesis of glomerular diseases. Curr Opin Nephrol Hypertens. 1994; 3: 54–58.PubMedCrossRefGoogle Scholar
  40. 40.
    Border WA, Noble NA. Transforming growth factor beta in tissue fibrosis. N Engl J Med. 1994; 331: 1286–1292.PubMedCrossRefGoogle Scholar
  41. 41.
    Sanderson N, Factor V, Nagy P, et al. Hepatic expression of mature transforming growth factor 01 in transgenic mice results in multiple tissue lesions. Proc Natl Acad Sci USA. 1992; 92: 2572–2576.CrossRefGoogle Scholar
  42. 42.
    Chegini N, Tang X-M, Ghahary A. Transforming growth factor-01 and relaxin interaction modulate the expression of extracellular matrix components in peritoneal adhesion fibroblats in vitro. 1996; submitted.Google Scholar
  43. 43.
    Kane CJM, Hebda PA, Mansbridge IN, Hanawalt PC. Direct evidence for spatial and temporal regulation of transforming growth factor b1 expression during cutaneous wound healing. J Cell Physiol. 1991; 148: 157–173.PubMedCrossRefGoogle Scholar
  44. 44.
    Nicola NA. Hemopoietic cell growth factors and their receptors. Annu Rev Biochem. 1989; 58: 45–77.PubMedCrossRefGoogle Scholar
  45. 45.
    Vyalov S, Desmouliere A, Gabbiani G. GM-CSF-induced granulation tissue formation: relationships between macrophages and myofibroblast accumulation. Virchous Arch B Cell Pathol. 1993; 63: 231–239.CrossRefGoogle Scholar
  46. 46.
    Jyung RW, We L, Piere GF, Mustoe TA. Granulocyte-macrophage colony-stimulating factor and granulocyte-colony-stimulating factor: differential action on incisional wound healing. Surgery. 1994; 115: 325–334.PubMedGoogle Scholar
  47. 47.
    Shah M, Foreman DM, Furguson MWJ. Neutralizing antibodies to TGF-13l,2 reduces cutanous scarring in adult rodents. J Cell Sci. 1994; 107: 1137–1357.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1997

Authors and Affiliations

  • Nasser Chegini

There are no affiliations available

Personalised recommendations